Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation

Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation

ABSTRACTBackground: The V617F mutation of Janus-associated kinase 2 (JAK2) is common in myeloproliferative neoplasms (MPN). JAK2 V617F mutation can be detected in patients with de novo acute myeloid leukemia (AML), but de novo acute promyelocytic leukemia (APL) with JAK2 V617F mutation is rare.Case...

Full description

Bibliographic Details
Main Authors: Yi-zhi Jiang, Zhong-ling Wei, Na-na Wang, Chen Huang, Jun Huang, Jia-wei Yan, Ran Wang, Zheng-zhi Yu, Dong-ping Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Acute promyelocytic leukemia (APL)
myeloproliferative neoplasms (MPN)
JAK2 v617f
PML/RARα
transformation
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2153200

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2153200

Similar Items